#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metastatic malignant melanoma Glycogen storage disease type II Pemphigoid Hepatitis D Familial hypertriglyceridaemia Malignant oligodendroglioma Cardiomyopathy Infertility female Gaucher's disease type I Giant cell tumour of tendon sheath Herpes simplex Post transplant lymphoproliferative disorder Precursor T-lymphoblastic lymphoma/leukaemia recurrent Mixed-type liposarcoma Breast angiosarcoma More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors – Treatment Basal cell naevus syndrome Tuberous sclerosis complex – Treatment Congenital generalised lipodystrophy – Life with Disease Fabry’s disease – Diagnostics Fragile X syndrome – Diagnostics Paraneoplastic neurological syndrome – Diagnostics SAPHO syndrome – Treatment Medulloblastoma recurrent – Basic Information Angiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tazobactam Sodium Anb032 Betaine Citrate Tinengotinib Ipatasertib Zidesamtinib DAPIGLUTIDE Av-Ec2023 VAMIFEPORT TRIHYDROCHLORIDE Perampanel 7-Ethyl-10-Hydroxycamptothecin GSKVX000000030810 ADMILPARANT Cpft Trifluoroacetate Exl01 Nafarelin OMTX705 Doxycycline GSK5764227 SARACATINIB More therapies…

    Learn about Your Condition

    Genitourinary tract neoplasm Essential thrombocythaemia Clinically isolated syndrome Burkitt's lymphoma Choroid melanoma Cardiac failure congestive Wiskott-Aldrich syndrome Haematological malignancy Endometrial stromal sarcoma Lichen sclerosus Thyroidectomy Endocrine disorder Petit mal epilepsy Retinoblastoma Eczema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Metabolism

  • Study on the Safety and Effectiveness of Elafibranor for Adults with Primary Sclerosing Cholangitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Elafibranor
    Germany Italy Portugal Spain

  • Study on the Effects of Verapamil Hydrochloride for Adults with Type 1 Diabetes to Preserve Beta-Cell Function

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Verapamil Hydrochloride Ph. Eur.
    • Verapamil Hydrochloride
    Austria Belgium France Germany Italy

  • Study on the Long-Term Safety of PTC923 (Sepiapterin) for Patients with Phenylketonuria

    Not recruiting

    3 1 1
    Investigated Drugs:
    • (S)-2-Amino-6-(2-Hydroxypropanoyl)-7,8-Dihydropteridin-4(3H)-One
    Czechia Denmark France Germany Italy The Netherlands +4

  • Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Zibotentan
    • Dapagliflozin
    Austria Bulgaria Denmark France Germany Italy +6

  • Study of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Op-1250
    • PALAZESTRANT
    • Anastrozole
    Austria Belgium Bulgaria Czechia France Germany +7

  • Study Comparing Sepiapterin and Sapropterin for Treating Phenylketonuria in Patients Aged 2 Years and Older

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Phenylketonuria
    Investigated Drugs:
    • (S)-2-Amino-6-(2-Hydroxypropanoyl)-7,8-Dihydropteridin-4(3H)-One
    • Sapropterin Dihydrochloride
    Czechia Denmark France Germany Italy The Netherlands +3
Previous Page
1 … 3 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!